Bio-MEMS Market By Type (Gyroscopes, Accelerometers), By Application (Neural Implants, Bionics, Ent Implants, Cardio-MEMS) - Growth, Share, Opportunities & Competitive Analysis, 2017 - 2025

This report on the global bio-MEMS market studies various bio-MEMS types and applications. To treat chronic illnesses, bio-MEMS employ micro-sized components such as sensors, transducers, actuators, and electronic devices. A large patient pool suffering from critical illness, cost-effectiveness, and better patient suitability are the driving factors for the bio-MEMS market. The applications of bio-MEMS are diverse and useful in drug delivery, diagnosis, cell culture studies, and personalized medication.

For the purpose of this study, the various types of bio-MEMS studied include gyroscopes, accelerometers, and others. Bio-MEMS applications studied in this report are neural implants, bionics, ENT implants, cardio-MEMS, and others. The global bio-MEMS market is segmented geographically into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa markets. 

Market size estimates and forecasts for these segments are provided in US$ Mn, along with the respective CAGRs for the period 2017-2025, using 2016 as the base year.This report also includes qualitative assessment factors such as market dynamics (drivers, restraints, and opportunities) to have a good understanding of the current and anticipated trends in the global bio-MEMS market. Competition assessment tools such as market attractiveness assessment and competitive landscape analysis by key players are also demonstrated in the study. Furthermore, this report concludes with a profile of key market players currently enjoying prominent positions in the global bio-MEMS market. The key players profiled in this report are Abbott Laboratories, Baxter International Inc., Becton Dickinson and Company, Boston Scientific Corporation, Bleuchiip Ltd., Lepu Medical Technology, OMRON Corporation, Perkin Elmer, Inc., St. Jude Medical, Inc., and Teledyne Dalsa, Inc.

Based on types, the global bio-MEMS market is categorized into:

  • Gyroscopes
  • Accelerometers
  • Others

Sophisticated microfabrication techniques are used in bio-MEMS to enable the treatment of critical diseases. The rise in demand for artificial limbs, personalized medication, high efficacy, and low cost is fueling the bio-MEMS market's growth. In 2016, accelerometers held the largest market due to technical innovations and wide application in the biomedical sector, e.g., the use of accelerometers in pacemakers has revolutionized the treatment of cardiac diseases.

The other devices segment is anticipated to register faster growth throughout the forecast period of 2017–2025, as it includes various bio-MEMS types such as flow sensors, microfluidics, DNA microarrays, micro-motors, etc. that find application in drug delivery, diagnosis, and cell culture studies. Overall, the global bio-MEMS market is highly competitive, with multiple players like Boston Scientific Corporation, Abbot Laboratories, Baxter International, Inc., Becton and Dickinson Company, etc., specializing in their respective fields. Consolidation activities are becoming more common on the competitive front, with the goal of increasing technological advancement in bio MEMS devices and related software for better patient compliance and making them affordable.

Based on application areas, the global bio-MEMS market is categorized into:

  • Neural implants
  • Bionics
  • ENT implants
  • Cardio-MEMS
  • Others

Because of its utility in assisting patients in surviving critical diseases, bio-MEMS has a wide range of applications. A rise in government grants to grow R&D for biomedical applications, a rise in the patient pool, and technological advancements in the patient monitoring system have fuelled the bio-MEMS application market. Cardio-MEMS held the largest market share among all application areas in 2016 due to the rise in cardiovascular diseases and technological advancements in cardio-MEMS that have provided medical practitioners with deeper insights, such as pressure changes of patients with greater clarity. The Others segment, which includes pressure sensors, exoskeletons, and retinal implants, will be the fastest-growing market throughout the forecast period of 2017–2025, as they have become more perceptible in the healthcare sector to serve as a personalized medication application.

For the purpose of this study, the global bio-MEMS market is categorized into three segments:

North America

  • U.S.
  • Canada


  • U.K.
  • Germany
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Mexico
  • rest of Latin America

Middle East and Africa

  • GCC
  • Rest of the Middle East and Africa

In 2016, North America was identified as the largest market for bio-MEMS. According to the Centers for Disease Control and Prevention, more than 830,000 Americans die each year due to critical illnesses such as cardiovascular diseases, stroke, and chronic pulmonary obstructive disease. The market's growth is mainly attributed to a large and perpetually increasing patient pool, an evolved reimbursement scenario favoring bio-MEMS use, and technological advancements in bio-MEMS design and manufacture.

According to the World Health Organization, around one-third of the European population above the age of 15 suffers from critical illnesses, with wide variations across constituent countries. Europe is expected to be the second-largest market due to high awareness related to early diagnosis, government and non-government organization grants to strengthen R&D facilities to launch bio-MEMS devices and regulatory approval for the bio-MEMS market. The growth of the Asia Pacific market for bio-MEMS is attributed to factors such as the rising prevalence of critical illnesses requiring medical intervention, a competitive market due to the manufacturers involved in bio-MEMS production, and increasing disposable income in these regions. However, factors such as developing health infrastructure, increasing awareness, and increasing demand for bio-MEMS are going to fuel the rapid growth of the bio-MEMS market in Latin America, the Middle East, and Africa in the near future.

Frequently Asked Questions:

The market for Bio-MEMS Market is expected to reach US$ 2,980 Mn By 2025.

The Bio-MEMS Market is expected to see significant CAGR growth over the coming years, at 12.33%.

The report is forecasted from 2017-2025.

The base year of this report is 2016.

Becton Dickinson and Company, Boston Scientific Corporation, Bleuchiip Ltd., Lepu Medical Technology, OMRON Corporation, Perkin Elmer, Inc., St. Jude Medical, Inc., and Teledyne Dalsa, Inc. are some of the major players in the global market.

Choose License Type
Trusted By
Published Date:  Jul 2017
Category:  Medical Devices
Report ID:   58545
Report Format:   PDF
Pages:   120
Rating:    4.6 (60)
Delivery Time: 24 Hours to 48 Hours   
Connect With Us
24/7 Research Support